Related Experiment Video
Updated: Aug 30, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
Moderate exercise and fibrinolytic potential in obese sedentary men with metabolic syndrome
Penelope J Morris1, C Ira Packianathan, Catherine J Van Blerk
1Centre for Obesity Research, Luton & Dunstable Hospital NHS Trust, Lewsey Road, Luton, Beds LU4 0DZ, United Kingdom. penny.morris@ldh-tr.anglox.nhs.uk
Objective:
To investigate the impact of 30-minute walking exercise at 70% VO2max on tissue plasminogen activator (t-PA) Ag and plasminogen activator inhibitor type 1 (PAI-1) Ag in obese sedentary males.
Research Methods And Procedures:
A controlled observational study of the effect of a 30-minute acute exercise bout at 70% VO2max on plasma t-PA antigen and PAI-1 antigen in 10 obese sedentary males matched for age, ethnic origin, and smoking status with 10 nonobese sedentary male controls.
Results:
The obese group remained hypofibrinolytic compared with the nonobese group at all time-points before, during, and after exercise. t-PA increased in both groups with exercise before returning to baseline values 30 minutes after exercise. PAI-1 did not significantly change in either group with exercise but rose significantly 30 minutes after exercise in the obese group.
Discussion:
The reduction in fibrinolytic potential in the obese group represents an increase in acute thrombotic risk and could account for the increased incidence of exercise-associated myocardial infarction observed in sedentary obese groups.
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Peripheral Artery Disease III: Interprofessional Care
